Not throwing away my shot. I am sorry folks...nothing of

New Post Public Reply Private Reply Replies (12) Message Board
jconst345 Goosebumps #83959
1,303
Not throwing away my shot.

I am sorry folks...nothing of substance to post here...except for how I felt about yesterday's call.

It was BY FAR the best call I've personally heard them conduct (in the past ~10 months).

They sounded the most optimistic, the most buttoned up & professional, the least speculative, and talked about the most optionality going forward. Btw, loved Arian (lawyer) setting the record straight on multiple questions, here here!

-EUA on the table, here & in multiple countries
-CD16 - Slam dunk trial will take care of the above if not granted sooner
-CD17 - could be an added subgroup for EUA, but will also pay dividends re: IV knowledge gained for both Covid & all future trials
-HIV receptor occupancy concerns addressed, underway, will be resolved, BLA filed summer, PDUFA at end of year/early 2022
-FDA is friend, not fiend (Mahboob & Nader's comments were both adamant & very reassuring to me)
-Pharma trial partnerships (no no no, please, let me pay the check) on the table
-Samsung revving their engines on our behalf w/ millions of vials of potential as needed
-100% receptor occupancy...wow
-World is aware of CYDY - as far south as Brazil, as far east as Hungary in Europe & Philippines in APAC
-Nader the bulldog has stamp of approval from board
-"Real" lawsuits are behind us, the others are fake news
-Long haulers anecdotes seem positive
-Cancer anecdotes seem positive
-And we all know anecdotes don't come off life support
-Cancer + all future trials/indications are so mind boggling it's hard to wrap my tiny brain around the potential...they are, in some cases, providing clemency for a death sentence. Imagine you are told you will die in 4-6 months, yet you are alive 12 months+, think about that... you don't get to play this game twice... what's that worth to you?

I absolutely love market inefficiencies, LOVE IT. I can buy 2-3x as much for the same $1 here as I could at $4.50 or $6.75. Literally doubling or tripling my eventual payout. Never thought I'd have the chance to add down at these prices, never. I'll take it as a win for me personally.

Kelly:
-'tumor microenvironment is loaded with ccr5'
-'future of Cytodyn is oncology'
-'Covid critical pales in comparison to opportunity in long haulers, long haulers absolutely pales in comparison to oncology'

How Mulholland doesn't jump off a cliff after answering yet another uplist question is beyond me. Torturous.

A few quick Buffett quotes, because he's the oracle for good reason:
"Opportunities come infrequently. When it rains gold, put out the bucket, not the thimble."

"Risk comes from not knowing what you're doing."

"You are neither right nor wrong because the crowd disagrees with you. You are right because your data and reasoning are right."

"Buy into a company because you want to own it, not because you want the stock to go up."
-->I actually feel unbelievably proud AND comfortable sitting on these shares. I am literally entrusting this team to my hard earned cash, I have no problem with that. This team are positive, focused, devoted, and sincere. I have no issue putting faith in them to do the right thing with my $$.

And my personal fav:
"The stock market is a device for transferring money from the impatient to the patient."

So, yes I'm CGiddy and have plenty of Goosebumps. I'll sit & meditate, as my techGURU has taught me, and say my "Ohm's" while waiting patiently for the long term story to play out. In the meantime I'll watch "If you believe in it, they will come" - BorelFields of Dreams. And to all the shorts out there, I'll soon misiu very much...as a HHIGambler, you gotta know when to fold em. Feeling smurphy about things as I can see Zaius on Mt. Olympus getting ready with his LLightning bolt, don't blink or you'll miss it. Float like a butterfly, calstang like a bee. You KenChowder down on that! Shout outs to all those I've missed, the good ones know who you are. ExCYDYng times ahead for Penicillin 2.0. Ali G signing off - Respert!

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Emotional Products Steal the Show at Canton Fair

Updated Category News Views 91

Canton Fair's Emotional Revolution Amidst the bustling aisles of the 140th Canton Fair in Guangzhou, something interesting has gotten folks buzzing. The market's tilting its head towards products that spark joy and dance with emotion, rather than just bland utility. That's right, the time-honored relationship between value and function is giving way to a softer kind of...

Continue Reading
SlidesAI Launches Standalone Platform for Presentations

Updated Category News Views 95

From Add-on to Standalone: SlidesAI's Big Leap You know what they say: time waits for no one, and that seems true in tech too. Those suit-and-tie presentation days? SlidesAI just took a swing at redefining them. Once a trusty sidekick locked into Google Slides, it's now captaining its own ship. Welcome to the SlidesAI standalone presentation platform—where AI meets your...

Continue Reading
3M's Huge Settlement: Navigating A Looming Legal Fog

Updated Category News Views 60

The latest chapter in 3M’s legal saga reads like a courtroom drama, but this time, the company's shelling out big bucks to sidestep prolonged courtroom battles. They're committing to a $5.8 billion payout over several years, aiming to put a lid on a massive batch of PFAS-related lawsuits. It’s like they’re cleaning the spill with a velvet mop, but the trick is...

Continue Reading
Felicitysolar's Global Reach and R&D Highlights

Updated Category News Views 92

Celebrating Partnerships and Achievements Felicitysolar ain't your run-of-the-mill energy outfit. On October 17, 2026, they rolled out the red carpet—or perhaps better put, the Pearl River—for their international distributors in Guangzhou. An event dubbed "Felicity Together — Together, We Create More" left no doubt that these folks are in it for the long haul with...

Continue Reading
FGII and tZERO Merger Under Scrutiny: Is it Fair?

Updated Category News Views 80

Sitting at the Crossroads of M&A Scrutiny Alright, it's time to put on our skeptical hats. Out in the world of mergers and acquisitions, not every deal glimmers with gold. You've got FG Imperii Acquisition Corp. (NASDAQ: FGII) under the lens, with a merger alongside tZERO Group, Inc. stirring up a storm. The folks over at Monteverde & Associates, an M&A Class Action Firm...

Continue Reading
Cboe Fights CFTC Over Single-Stock Derivative Approval

Updated Category News Views 149

The Battle Begins: Cboe's Legal Action Cboe Global Markets, the big kahuna in the equities and index derivatives scene, ain't just rolling over quietly. They've hopped on board with the Capital Markets Alliance in a legal dust-up against the Commodity Futures Trading Commission's (CFTC) decision to allow perpetual derivatives on U.S. stocks and ETFs. We're talking major...

Continue Reading
DUPR Teams Up with InBody to Elevate Pickleball Fitness

Updated Category News Views 81

Well, here's a twist in the pickleball world—DUPR and InBody have struck a deal to bring top-notch body composition tech to the ever-expanding universe of pickleballers. They're merging power players from two different worlds to tap into your performance on the court and your wellness off it. Maybe I'm just jaded from too many marketing pitches, but this one could...

Continue Reading
Direct Connection Unveils Enthusiast-Centric Parts at SEMA

Updated Category News Views 95

Pumping Up the Horsepower at SEMA 2026 Las Vegas is buzzing with horsepower this November as Direct Connection, the performance arm of Stellantis, unleashes a fresh wave of factory-backed adrenaline at the 2026 SEMA show. Among all the glitter and roar, this isn't just hype—it's the real deal for Mopar fans. Riding High on Factory-Backed Power For the folks knee-deep in...

Continue Reading
AlphaESS Stretches Influence with Adriatic Energy Boost

Updated Category News Views 80

AlphaESS Charges into the Adriatic Region Kicking off with a bang in Zagreb, AlphaESS didn't just show up at the Green Energy Fair 2026—they turned the spotlights on their expanding role across the Adriatic region. This ain't your run-of-the-mill industry showcase. They've been busy throwing up energy storage units like they're growing crops. With a strong lineup...

Continue Reading
Tigo Energy Faces Legal Heat Over Fraud Allegations

Updated Category News Views 80

Tigo Energy's Legal Battle Heats Up If you haven't been paying attention, it’s time to get your eyes on Tigo Energy (NASDAQ: TYGO). The company is now in the hot seat with a securities fraud lawsuit that's got investors on edge. This isn’t just a minor squabble; we're talking about allegations that could shake the ground beneath its share price. The Claims and...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Investor Sentiment Towards Modine Manufacturing

Updated Category News Views 127

Investing in Modine Manufacturing: Current Trends Modine Manufacturing (NYSE: MOD) has seen a notable rise in its short percent of float, which currently stands at 11.64%. Recent reports indicate that 4.49 million shares have been sold short, amounting to 9.78% of all shares available for trading. Given the current trading volume, traders would need approximately 2.83...

Continue Reading
Amazon MGM Studios Reinvents James Bond for Future Generations

Updated Category News Views 422

Amazon MGM Studios Takes Charge of the Bond Legacy Amazon.com Inc (NASDAQ: AMZN) owned MGM Studios has embarked on a groundbreaking partnership with Michael G. Wilson and Barbara Broccoli, the long-time stewards of the iconic James Bond franchise. This collaboration is set to steer the creative direction of future Bond films, marking a significant evolution in the series...

Continue Reading
Presidio's Strategic Acquisition of Ergo: A New Era in Tech

Updated Category News Views 397

Presidio Expands Its Reach with the Acquisition of Ergo Global technology services provider, Presidio, has taken an exciting leap by signing a definitive agreement to acquire Ergo, a prominent IT solutions and managed services provider headquartered in Ireland. This strategic move is not just an expansion; it signifies a commitment to enhancing digital transformation...

Continue Reading
Medicaid Work Requirements Stir Controversy and Concerns

Updated Category News Views 22

Medicare & Medicaid's New Rules Under Fire Folks, the Centers for Medicare & Medicaid Services just dropped a bombshell with their latest interim final rule. This one's got the Allergy & Asthma Network riled up like a hornet's nest on a humid summer day. We're talking work requirements for Medicaid benefits, folks, and it ain't sitting pretty—especially with those...

Continue Reading
Managerial Transactions at Royal Unibrew: Key Insights

Updated Category News Views 103

Understanding Managerial Transactions at Royal Unibrew A/S In the dynamic world of corporate governance, transparency in managerial transactions is essential. Royal Unibrew A/S has taken proactive steps to maintain this transparency in accordance with EU regulations. This article outlines the key details regarding recent transactions executed by individuals discharging...

Continue Reading